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Attributing Cause 
of Death for 
Patients with 
Clostridium diffi cile 
Infection
To the Editor: Hota et al. report 
that for deceased patients who had 
Clostridium diffi cile infection (CDI), 
agreement is poor between causes of 
death reported on death certifi cates and 
those categorized by a review panel 
(1). Our data support the diffi culty of 
attributing cause of death for patients 
with CDI.
In 2004 in Quebec, Canada, a 
mandatory CDI surveillance program 
was implemented. Deaths that occurred 
within 30 days after CDI diagnosis were 
classifi ed as 1) directly attributable 
to CDI (e.g., toxic megacolon, septic 
shock), 2) having a CDI contribution 
(e.g., acute decompensation of 
chronic heart failure), or 3) unrelated 
to CDI (e.g., terminal cancer) (2). To 
determine accuracy of the surveillance 
classifi cations, we compared cause-of-
death classifi cation of 22 deceased CDI 
patients reported to surveillance by 1 
hospital in 2007 with causes of death 
reported by 13 external reviewers who 
examined summaries of medical fi les 
of the deceased patients. Reviewers 
were 11 infectious disease and 2 
public health physicians involved with 
CDI surveillance at their respective 
hospitals but not this hospital. The 
median (minimal, maximal) κ statistics 
for comparison of external reviews 
with surveillance classifi cation were 
0.495 (0.252, 0.607) for directly 
attributable, 0.182 (−0.091, 0.182) for 
contributed, and 0.321 (0.124, 0.614) 
for unrelated. Comparison within 
external reviewers yielded 0.697 
(0.394, 1.0), 0.233 (−0.294, 0.703), 
and 0.542 (0.154, 0.909), respectively. 
Complete agreement was found for 
only 6 cases (4 directly attributable and 
2 unrelated) (Figure). 
Variation among reviewers sug-
gested that categorizations reported to 
surveillance were inaccurate. Number 
of deaths among patients with CDI, 
regardless of the cause of death, 
seemed to better indicate CDI severity. 
Since 2008, only the crude numbers 
of deaths, not subjected to individual 
interpretation, have been reported 
to surveillance. A questionnaire 
addressing concurrent medical 
conditions, prognosis, level of care, 
and circumstances of death is being 
implemented in Quebec hospitals 
participating in CDI surveillance and 
should help determine the role of CDI 
in deaths. 
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Figure. Classifi cation of cause of death among 22 patients with Clostridium diffi cile 
infection (CDI), by 13 external reviewers, Quebec, Canada, 2007. Bars indicate the number 
of reviewers who assigned each category. Gray bars indicate that CDI was unrelated to 
death, white bars indicate that CDI contributed to death, and black bars indicate that death 
was directly attributable to CDI.
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Characterization 
of Mycobacterium 
orygis
To the Editor: In a recently 
published study, van Ingen et 
al. (1) described the molecular 
characterization and phylogenetic 
position of the oryx bacillus, a 
member of the Mycobacterium 
tuberculosis complex, and proposed a 
long overdue name for the organism: 
Mycobacterium orygis. The authors 
described oryx bacillus as a separate 
taxon; the aim was for this description 
to be used in the future to identify 
the subspecies. Thus, we thought 
it pertinent to provide additional 
information that would be useful in 
speciating isolates of the oryx bacillus.
In a recent study, we genotyped an 
isolate of oryx bacillus obtained from 
an African buffalo in South Africa (2). 
This isolate was typed by using 16S 
rDNA, M. tuberculosis complex–
specifi c multiplex-PCR, regions-of-
difference analyses, gyrase B gene 
single nucleotide polymorphism 
(SNP) analysis, spoligotyping, and 
mycobacterial interspersed repetitive 
units–variable number tandem repeat 
typing. We showed that, in addition to 
the markers described by van Ingen et 
al. (1), regions of difference 701 and 
702 were also intact in M. orygis.
In addition, van Ingen et al. 
identifi ed the Rv204238 GGC mutation 
as a novel, useful genetic marker to 
identify M. orygis. However, such a 
marker already exists in the form of 
the very specifi c gyrBoryx G to A SNP 
at position 1113, which was described 
by Huard et al. (3). On its own, SNP 
detection in the gyrB gene allows 
differentiation of at least 6 of the 9 
M. tuberculosis complex species from 
each other (M. canettii, M. tuberculosis, 
M. orygis, M. microti, M. caprae, and 
M. bovis) (3). Thus, the SNP at position 
1113 is more useful than the Rv204238 
mutation as a novel and distinct genetic 
marker to identify M. orygis.
Apart from this, we found that 
the sequence type (ST) 587 was not 
the only spoligotype specifi c for M. 
orygis. In our study, the variant type 
ST701 (annotated as M. africanum in 
the spolDB4 database) (4) is also an 
M. orygis–specifi c type and exactly 
matches that of a previous isolate of 
the oryx bacillus (SB0319) from the 
M. bovis spoligotype database (5). 
This spoligotype differs from ST587 
by the presence of spacer 18, and 
the spoligotype was not found in the 
extensive sample set of van Ingen et 
al. (1).
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